Delisting risk
Heron Therapeutics
Sells U.S. hospital injectables for postsurgical pain and nausea prevention.
$0.3321
After-hours close+0.01 (+2.63%)
At close$0.3236(−2.56%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 71.27%134.90M sharesInsiders 5.65%10.70M sharesOther 23.08%43.69M shares
Shares outstanding 189.28M · Float 135.44M · 71.6% free float
Institutions13F, as of Jun 30, 2026
169 holders · 134.90M shares · 23 new positions · 80 increased · 39 reduced · 26 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Rubric Capital Management LP | 30.05M | 15.87% | 0 | Aug 14, 2026 |
| Clearline Capital LP | 11.38M | 6.01% | −851.3K | Aug 14, 2026 |
| BlackRock, Inc. | 10.55M | 5.57% | +444.3K | Aug 7, 2026 |
| Velan Capital Investment Management LP | 8.75M | 4.62% | 0 | Aug 14, 2026 |
| Vanguard Capital Management LLC | 7.78M | 4.11% | −27.6K | Aug 13, 2026 |
| Tejara Capital Ltd | 6.51M | 3.44% | +174.0K | Aug 11, 2026 |
| Tang Capital Management LLC | 6.25M | 3.30% | 0 | Aug 14, 2026 |
| Geode Capital Management, LLC | 4.27M | 2.26% | +260.9K | Aug 12, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Rubric Capital Management LPincl. David Rosen | 15.90% | 30.05M | 13D | Oct 17, 2025 ↗ |
| Clearline Capital LP | 6.70% | 12.24M | 13G | Feb 17, 2026 ↗ |
| Adage Capital Management, L.P.incl. Robert Atchinson, Phillip Gross | 5.84% | 8.85M | 13G | Nov 12, 2024 ↗ |
| BlackRock, Inc. | 5.60% | 8.53M | Oct 24, 2024 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Rubric Capital Management LP | 10 percent owner | 30.05M | 15.87% | Oct 17, 2025 |
| Adam Morgan | director | 8.88M | 4.69% | Feb 3, 2026 |
| Craig A. Collard | director, officer: Chief Executive Officer | 856.5K | 0.45% | Aug 3, 2026 |
| Ira Duarte | officer: EVP, Chief Financial Officer | 281.9K | 0.15% | Aug 3, 2026 |
| William P. Forbes | officer: EVP, Chief Development Officer | 241.2K | 0.13% | Aug 3, 2026 |
| Mark Earl Hensley | officer: Chief Operating Officer | 170.9K | 0.09% | Aug 10, 2026 |
| Waage Christian | director | 54.0K | 0.03% | Feb 3, 2026 |
| Thomas Cusack | director | 54.0K | 0.03% | Feb 3, 2026 |
| Sharmila Dissanaike | director | 54.0K | 0.03% | Feb 3, 2026 |
| Craig A. Johnson | director | 54.0K | 0.03% | Feb 3, 2026 |
10 ten-percent owners hold 38.02M shares by Form 4 — the 13D/G table above shows those stakes, the figure above counts officers and directors only · 22 people have not refiled in the last 18 months (570.4K shares), so they are not in the figure above
Latest trades
No open-market trades in the last 12 months.
CongressHouse and Senate disclosures
Not reported.